Concepedia

Ingalill Friis–Liby

IF

Statistics

Publications

11

Citations

2K

H-Index

11

Active since

2004

Affiliations

Sahlgrenska University Hospital(Current)

Karolinska University Hospital

Örebro University Hospital

Linköping University

Lund University

Ingalill Friis–Liby is an author at Sahlgrenska University Hospital specializing in inflammatory bowel disease, medicine, and pharmacotherapy.

Publications per year

2004–2022

11

Publications

11

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Gunnar Järnerot, Erik Hertervig, Ingalill Friis–Liby et al. · Gastroenterology · 2005 · 1.1K citations · Full text

, , +15

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

A. Gustavsson, G Järnerot, Erik Hertervig et al. · Alimentary Pharmacology & Therapeutics · 2010 · 180 citations

, , +12

Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis

Lina Lindström, Rolf Hultcrantz, Kirsten Muri Boberg et al. · Clinical Gastroenterology and Hepatology · 2013 · 178 citations

, , +11

High prevalence of metabolic complications in patients with non‐alcoholic fatty liver disease

Ingalill Friis–Liby, Frank Aldenborg, Pernilla Jerlstad et al. · Scandinavian Journal of Gastroenterology · 2004 · 103 citations

, , +15

Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients

M. Sjöberg, Anders Magnuson, Jan Björk et al. · Alimentary Pharmacology & Therapeutics · 2013 · 86 citations

, , +17

1–5 of 11